Crinecerfont: A promising compound for reducing corticosteroid dependence in CAH patients

FHS
June 11, 2024
3:45 am

People born with the common form of congenital adrenal hyperplasia lack an enzyme in the adrenal glands needed to make the hormones cortisol and aldorsterone, which are involved in the body’s response to stress and blood pressure regulation.

Theratechnologies’ HIV drug to face supply issues in 2025 over third-party facility shutdown

Another pharma company is facing supply constraints because of third-party contract manufacturing issues. On Tuesday, Theratechnologies warned there is a risk its lipodystrophy drug for

September 19, 2024

Can MRIs ensure prostate cancer screening does more good than harm?

Prostate cancer presents a tricky screening challenge. Catching it early could mean dodging a painful journey with advanced cancer. Yet a sizable majority of prostate

September 25, 2024

Protein intake during pregnancy affects offspring’s facial features

The protein content of the diet during pregnancy can affect the face of the offspring. This is shown in animal studies, and the underlying mechanism

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.